| 1. |
|
|
| 2. |
|
|
| 3. |
- Ackermann, M., et al.
(författare)
-
Gamma-ray observations of the orion molecular clouds with the fermi large area telescope
- 2012
-
Ingår i: Astrophysical Journal. - 0004-637X .- 1538-4357. ; 756:1, s. 4-
-
Tidskriftsartikel (refereegranskat)abstract
- We report on the gamma-ray observations of giant molecular clouds Orion A and B with the Large Area Telescope (LAT) on board the Fermi Gamma-ray Space Telescope. The gamma-ray emission in the energy band between similar to 100 MeV and similar to 100 GeV is predicted to trace the gas mass distribution in the clouds through nuclear interactions between the Galactic cosmic rays (CRs) and interstellar gas. The gamma-ray production cross-section for the nuclear interaction is known to similar to 10% precision which makes the LAT a powerful tool to measure the gas mass column density distribution of molecular clouds for a known CR intensity. We present here such distributions for Orion A and B, and correlate them with those of the velocity-integrated CO intensity (W-CO) at a 1 degrees x 1 degrees pixel level. The correlation is found to be linear over a W-CO range of similar to 10-fold when divided in three regions, suggesting penetration of nuclear CRs to most of the cloud volumes. The W-CO-to-mass conversion factor, X-CO, is found to be similar to 2.3 x 10(20) cm(-2) (K km s(-1))(-1) for the high-longitude part of Orion A (l > 212 degrees), similar to 1.7 times higher than similar to 1.3 x 10(20) found for the rest of Orion A and B. We interpret the apparent high XCO in the high-longitude region of Orion A in the light of recent works proposing a nonlinear relation between H-2 and CO densities in the diffuse molecular gas. W-CO decreases faster than the H-2 column density in the region making the gas "darker" to W-CO.
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
- Shrestha, R, et al.
(författare)
-
Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status
- 2020
-
Ingår i: Blood advances. - : American Society of Hematology. - 2473-9537 .- 2473-9529. ; 4:5, s. 845-854
-
Tidskriftsartikel (refereegranskat)abstract
- Loss-of-function mutations in ten-eleven translocation-2 (TET2) are recurrent events in acute myeloid leukemia (AML) as well as in preleukemic hematopoietic stem cells (HSCs) of age-related clonal hematopoiesis. TET3 mutations are infrequent in AML, but the level of TET3 expression in HSCs has been found to decline with age. We examined the impact of gradual decrease of TET function in AML development by generating mice with Tet deficiency at various degrees. Tet2f/f and Tet3f/f mice were crossed with mice expressing Mx1-Cre to generate Tet2f/wtTet3f/fMx-Cre+ (T2ΔT3), Tet2f/fTet3f/wtMx-Cre+ (ΔT2T3), and Tet2f/fTet3f/fMx-Cre+ (ΔT2ΔT3) mice. All ΔT2ΔT3 mice died of aggressive AML at a median survival of 10.7 weeks. By comparison, T2ΔT3 and ΔT2T3 mice developed AML at longer latencies, with a median survival of ∼27 weeks. Remarkably, all 9 T2ΔT3 and 8 ΔT2T3 mice with AML showed inactivation of the remaining nontargeted Tet2 or Tet3 allele, respectively, owing to exonic loss in either gene or stop-gain mutations in Tet3. Recurrent mutations other than Tet3 were not noted in any mice by whole-exome sequencing. Spontaneous inactivation of residual Tet2 or Tet3 alleles is a recurrent genetic event during the development of AML with Tet insufficiency.
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
|
|
